TCM
PASG icon

Tang Capital Management’s Passage Bio PASG Stock Holding History

Tang Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75,000
Closed -$602K – 159
2025
Q3 		$602K Hold
75,000
– – 0.02% 167
2025
Q2 		$600K Hold
75,000
– – 0.03% 182
2025
Q1 		$530K Hold
75,000
– – 0.03% 182
2024
Q4 		$851K Hold
75,000
– – 0.06% 163
2024
Q3 		$1.05M Hold
75,000
– – 0.08% 107
2024
Q2 		$1.19M Hold
75,000
– – 0.12% 89
2024
Q1 		$2.02M Sell
75,000
-45,000
-38% -$1.08M 0.21% 78
2023
Q4 		$2.42M Buy
120,000
+100,000
+500% +$1.38M 0.22% 85
2023
Q3 		$263K Buy
20,000
+5,000
+33% +$82.1K 0.04% 103
2023
Q2 		$282K Hold
15,000
– – 0.04% 94
2023
Q1 		$287K Buy
+15,000
New +$407K 0.04% 91

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Tang Capital Management's PASG Position: Q4 2025 in Review

Tang Capital Management sold out of Passage Bio (PASG) in Q4 2025, closing a stake of 75,000 shares — an estimated $602K sold.

Tang Capital Management first reported a position in PASG in Q1 2023 and held it in 11 quarters. The position peaked at $2.42M in Q4 2023. 30 funds tracked by Wall St. Rank hold PASG as of Q4 2025.

  • Tang Capital Management reported no remaining Passage Bio position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 75,000 Passage Bio shares in Q4 2025, an estimated $602K.
  • Tang Capital Management first reported a position in Passage Bio in Q1 2023 and held it in 11 quarters.
  • Tang Capital Management's Passage Bio position peaked at $2.42M in Q4 2023.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.